|
WO2003010201A2
(en)
*
|
2001-07-20 |
2003-02-06 |
Absorber, Ab |
Blood group antigen fusion polypeptides and methods of use thereof
|
|
AU2003228067B2
(en)
*
|
2002-04-22 |
2008-05-29 |
Recopharma Ab |
Mucin fusion polypeptide vaccines, compositions and methods of use thereof
|
|
WO2003089450A2
(en)
*
|
2002-04-22 |
2003-10-30 |
Recopharma Ab |
Fusion polypeptides and methods for inhibiting microbial adhesion
|
|
JP5183010B2
(ja)
|
2002-05-16 |
2013-04-17 |
グリコミメティクス， インコーポレイテッド |
セレクチンによって媒介される機能を阻害するための化合物および方法
|
|
AU2003245595A1
(en)
*
|
2002-07-03 |
2004-01-23 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
|
|
US7638323B2
(en)
*
|
2002-08-09 |
2009-12-29 |
Recopharma Ab |
Fusion proteins and methods of producing same
|
|
US20050076759A1
(en)
*
|
2003-10-08 |
2005-04-14 |
Brian Westfall |
Linear saw with stab-cut bevel capability
|
|
US20040219158A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
|
|
US7459523B2
(en)
*
|
2003-11-12 |
2008-12-02 |
Wisconsin Alumni Research Foundation |
Equine P-selectin glycoprotein ligand-1 and uses thereof
|
|
CA2546784A1
(en)
*
|
2003-11-19 |
2005-06-16 |
Glycomimetics, Inc. |
Glycomimetic antagonists for both e- and p-selectins
|
|
DE602004011272T2
(de)
*
|
2003-11-19 |
2008-12-24 |
Glycomimetics, Inc. |
Spezifischer antagonist sowohl für e- als auch p-selektine
|
|
WO2006001348A1
(ja)
*
|
2004-06-23 |
2006-01-05 |
Japan Science And Technology Agency |
浸潤抑制及び細胞殺傷剤
|
|
US8201377B2
(en)
*
|
2004-11-05 |
2012-06-19 |
Faus Group, Inc. |
Flooring system having multiple alignment points
|
|
US20090036386A1
(en)
*
|
2005-05-25 |
2009-02-05 |
Glycomimetics, Inc |
Heterobifunctional compounds for selectin inhibition
|
|
WO2007021721A2
(en)
*
|
2005-08-09 |
2007-02-22 |
Glycomimetics, Inc. |
Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
|
|
SI2264043T1
(en)
|
2005-09-02 |
2018-01-31 |
Glycomimetics, Inc. |
HETEROBIFUNCTIONAL PAN-SELECTINE INHIBITORS
|
|
WO2007033221A2
(en)
*
|
2005-09-13 |
2007-03-22 |
The General Hospital Corporation |
Methods and compositions for inhibition of immune responses
|
|
WO2007132355A2
(en)
*
|
2006-01-26 |
2007-11-22 |
Recopharma Ab |
Compositions and methods for inhibiting viral adhesion
|
|
US20070178447A1
(en)
*
|
2006-01-31 |
2007-08-02 |
Bethyl Laboratories, Inc. |
Method for decreasing interference in results of immunochemical methods
|
|
US20090176717A1
(en)
*
|
2006-06-01 |
2009-07-09 |
Glycomimetics, Inc. |
Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
|
|
US7964569B2
(en)
|
2006-10-12 |
2011-06-21 |
Glycomimetics, Inc. |
Glycomimetic replacements for hexoses and N-acetyl hexosamines
|
|
US7998486B2
(en)
|
2006-10-25 |
2011-08-16 |
Newlink Genetics Corporation |
Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
|
|
WO2008100453A1
(en)
*
|
2007-02-09 |
2008-08-21 |
Glycomimetics, Inc. |
Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
|
|
US8039442B2
(en)
*
|
2007-07-18 |
2011-10-18 |
Glycomimetics, Inc. |
Compounds and methods for treatment of sickle cell disease or complications associated therewith
|
|
US8895510B2
(en)
*
|
2008-04-08 |
2014-11-25 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
|
US8518896B2
(en)
*
|
2008-06-13 |
2013-08-27 |
Glycomimetics, Inc. |
Treatment of cancers of the blood using selected glycomimetic compounds
|
|
AU2010241807B2
(en)
|
2009-05-01 |
2014-08-14 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
|
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
|
US8921328B2
(en)
|
2010-09-14 |
2014-12-30 |
Glycomimetics, Inc. |
E-selectin antagonists
|
|
CN103501804A
(zh)
*
|
2010-12-21 |
2014-01-08 |
雷科制药公司 |
眼泪替代物
|
|
EP2794626B3
(en)
|
2011-12-22 |
2020-08-05 |
GlycoMimetics, Inc. |
E-selectin antagonist compounds
|
|
HUE038423T2
(hu)
|
2012-12-07 |
2018-10-29 |
Glycomimetics Inc |
E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára
|
|
CN107108679B
(zh)
|
2014-12-03 |
2020-10-23 |
糖模拟物有限公司 |
E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂
|
|
WO2017127422A1
(en)
|
2016-01-22 |
2017-07-27 |
Glycomimetics, Inc. |
Glycomimetic inhibitors of pa-il and pa-iil lectins
|
|
US11291678B2
(en)
|
2016-03-02 |
2022-04-05 |
Glycomimetics, Inc |
Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
|
|
US11433086B2
(en)
|
2016-08-08 |
2022-09-06 |
Glycomimetics, Inc. |
Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
|
|
BR112019006642A2
(pt)
|
2016-10-07 |
2019-07-02 |
Glycomimetics Inc |
antagonistas multiméricos de e-selectina altamente potentes
|
|
CA3054605A1
(en)
|
2017-03-15 |
2018-09-20 |
Glycomimetics, Inc. |
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
|
|
EP3717013A1
(en)
|
2017-11-30 |
2020-10-07 |
GlycoMimetics, Inc. |
Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
|
|
US11548908B2
(en)
|
2017-12-29 |
2023-01-10 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
|
AU2019230013A1
(en)
|
2018-03-05 |
2020-09-10 |
Glycomimetics, Inc. |
Methods for treating acute myeloid leukemia and related conditions
|
|
US20210260250A1
(en)
*
|
2018-06-12 |
2021-08-26 |
Rush University Medical Center |
Methods for Enhanced Endothelialization of Implanted Material
|
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|